Merck
CN
Search Within

303836

Applied Filters:
Keyword:'303836'
Showing 1-8 of 8 results for "303836" within Papers
Corinne Barbey et al.
Journal of proteome research, 11(1), 206-216 (2011-11-17)
Gamma-caprolactone (GCL) is well-known as a food flavor and has been recently described as a biostimulant molecule promoting the growth of bacteria with biocontrol activity against soft-rot pathogens. Among these biocontrol agents, Rhodococcus erythropolis, characterized by a remarkable metabolic versatility
H Thoma et al.
Journal of chromatography, 309(1), 17-32 (1984-07-13)
A two-step ultrafiltration method combined with anion-exchange chromatography is described for the separation of lipophilic and strongly lipophobic acids occurring in human blood, serum and plasma. After treatment with diazomethane, the acid fractions are separated further by gas chromatography. The
Amélie Cirou et al.
Research in microbiology, 162(9), 945-950 (2011-02-04)
Bacteria degrading quorum sensing (QS) signals have been proposed as biocontrol agents able to quench QS-dependent expression of virulence symptoms caused by Pectobacterium on potato plants. We report here that gamma-caprolactone (GCL) treatment stimulated growth of the native QS-degrading bacterial
Olga Khersonsky et al.
Biochemistry, 44(16), 6371-6382 (2005-04-20)
PON1 is the best-studied member of a family of enzymes called serum paraoxonases, or PONs, identified in mammals (including humans) and other vertebrates as well as in invertebrates. PONs exhibit a range of important activities, including drug metabolism and detoxification
Cindy Chung et al.
Biomaterials, 30(26), 4287-4296 (2009-05-26)
The potential of mesenchymal stem cells (MSCs) as a viable cell source for cartilage repair hinges on the development of engineered scaffolds that support adequate cartilage tissue formation. Evolving networks (hydrogels with mesh sizes that change over time due to
New thermosets obtained by the cationic copolymerization of diglycidyl ether of bisphenol A with ?-caprolactone with an improvement in the shrinkage. I. Study of the chemical processes and physical characteristics.
Gonzalez S, et al.
Journal of Polymer Science Part A: Polymer Chemistry, 45(10), 1968-1979 (2007)
Profile of volatile metabolites in human urine.
A Zlatkis et al.
Clinical chemistry, 17(7), 592-594 (1971-07-01)
Laura E Korhonen et al.
Journal of medicinal chemistry, 48(11), 3808-3815 (2005-05-27)
The purpose of this study was to determine the cytochrome P450 1A2 (CYP1A2) inhibition potencies of structurally diverse compounds to create a comprehensive three-dimensional quantitative structure-activity relationship (3D-QSAR) model of CYP1A2 inhibitors and to use this model to predict the
Page 1 of 1